til
Generic: Tumor Infiltrating lymphocytes
til: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. (CMBG) | Preclinical |
Get deeper analysis on til
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis